D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
ARS Pharmaceuticals
SPRY
$579M
| $2.5M | ﹤0.01% |
250,580
+40,453
| +19% | +$998K |
|
|
STRE
2677
DELISTED
Supernova Partners Acquisition Company III, Ltd.
STRE
| $2.5M | ﹤0.01% |
257,300
+173,967
| +209% | +$1.69M |
|
2678
PUT
Cinemark Holdings
CNK
$4.07B
| $2.5M | ﹤0.01% |
130,000
+44,200
| +52% | +$751K |
|
2679
Orchestra BioMed
OBIO
$228M
| $2.5M | ﹤0.01% |
252,518
+222,717
| +747% | +$2.2M |
|
2680
Ambev
ABEV
$47.9B
| $2.49M | ﹤0.01% |
903,664
-2,016,627
| -69% | -$6.38M |
|
|
APLS
2681
DELISTED
Apellis Pharmaceuticals
APLS
| $2.49M | ﹤0.01% |
75,522
-169,507
| -69% | -$9.52M |
|
|
BZUN
2682
PUT
Baozun
BZUN
$179M
| $2.49M | ﹤0.01% |
+142,000
| New | +$3.49M |
|
2683
CALL
Interactive Brokers
IBKR
$38.4B
| $2.49M | ﹤0.01% |
159,600
-75,600
| -32% | -$1.19M |
|
2684
PUT
Devon Energy
DVN
$51.3B
| $2.49M | ﹤0.01% |
70,000
| – | – |
|
|
CPE
2685
CALL
DELISTED
Callon Petroleum Company
CPE
| $2.48M | ﹤0.01% |
50,600
-75,100
| -60% | -$2.91M |
|
2686
CALL
Corpay
CPAY
$25.7B
| $2.48M | ﹤0.01% |
+9,500
| New | +$2.46M |
|
|
MSPR
2687
DELISTED
MSP Recovery Inc
MSPR
| $2.48M | ﹤0.01% |
57
-11
| -16% | -$476K |
|
2688
Clean Harbors
CLH
$17.2B
| $2.47M | ﹤0.01% |
+23,809
| New | +$2.34M |
|
2689
CALL
Weibo
WB
$1.97B
| $2.46M | ﹤0.01% |
51,900
+46,700
| +898% | +$2.52M |
|
2690
Dorman Products
DORM
$4.22B
| $2.46M | ﹤0.01% |
26,024
+10,437
| +67% | +$1.03M |
|
2691
Lindsay Corp
LNN
$1.14B
| $2.46M | ﹤0.01% |
16,229
-67
| -0.4% | -$10.8K |
|
|
LDHA
2692
DELISTED
LDH Growth Corp I Class A Ordinary Shares
LDHA
| $2.45M | ﹤0.01% |
250,500
+217,167
| +652% | +$2.11M |
|
2693
CALL
Host Hotels & Resorts
HST
$17.5B
| $2.45M | ﹤0.01% |
150,000
| – | – |
|
2694
Ovid Therapeutics
OVID
$427M
| $2.45M | ﹤0.01% |
728,930
-16,985
| -2% | -$61.9K |
|
|
NKGN
2695
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
| $2.45M | ﹤0.01% |
+252,656
| New | +$2.46M |
|
|
XPOA
2696
DELISTED
DPCM Capital, Inc.
XPOA
| $2.45M | ﹤0.01% |
+250,335
| New | +$2.45M |
|
|
AVID
2697
DELISTED
Avid Technology Inc
AVID
| $2.44M | ﹤0.01% |
84,344
+69,163
| +456% | +$2.14M |
|
|
WPCA
2698
DELISTED
Warburg Pincus Capital Corporation I-A
WPCA
| $2.44M | ﹤0.01% |
248,133
+164,800
| +198% | +$1.61M |
|
|
LJPC
2699
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $2.44M | ﹤0.01% |
610,654
-36,874
| -6% | -$146K |
|
|
PAFOU
2700
DELISTED
Pacifico Acquisition Corp. Units
PAFOU
| $2.44M | ﹤0.01% |
+240,000
| New | +$2.42M |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.